glp-1 research studies Mapping the effectiveness and risks of receptor agonists Ichor Research in Syracuse explores
Description
| As part of its investor day on Thursday, Cigna's Evernorth arm announced an expansion to its GLP-1 management solution as well as the launch of a new behavioral health-focused medical group.
Alex Zhavoronkov, discussed how the GLP-1 revolution is expanding beyond weight loss toward healthy longevity
on the healthcare industry.
Learn about food noise, how GLP-1 meds like Wegovy and Zepbound can reduce it, and get tips for managing breakthrough food noise during therapy.
Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data
